Back
LivaNova PLC 10K Form
Sell
36
LIVN
LivaNova PLC
Last Price:
52.10
Seasonality Move:
7.62%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-01 | 10Q | LIVN/LivaNova PLC Quarterly |
2023-07-26 | 10Q | LIVN/LivaNova PLC Quarterly |
2023-05-03 | 10Q | LIVN/LivaNova PLC Quarterly |
2022-11-02 | 10Q | LIVN/LivaNova PLC Quarterly |
2022-08-03 | 10Q | LIVN/LivaNova PLC Quarterly |
2022-05-04 | 10Q | LIVN/LivaNova PLC Quarterly |
Receive LIVN News And Ratings
See the #1 stock for the next 7 days that we like better than LIVN
LIVN Financial Statistics
Sales & Book Value
Annual Sales: | $1.15B |
---|---|
Cash Flow: | $32.85M |
Price / Cash Flow: | 25.79 |
Annual Sales: | $24.13 |
Price / Book: | 2.13 |
Profitability
EPS (TTM): | 0.42000 |
---|---|
Net Income (TTM): | $23.68M |
Gross Margin: | $771.25M |
Return on Equity: | 1.89% |
Return on Assets: | 0.97% |
LivaNova PLC Earnings Forecast
Key LivaNova PLC Financial Ratios
- The Gross Profit Margin over the past 31 years for LIVN is 66.86%.
- The Selling, General & Administrative Expenses for LIVN have been equal to 44.92% of Gross Profit Margin.
- The Research & Development expenses have been 16.80% of Revenue.
- The Interest Expense is 335.42% of Operating Income.
- The Net Earning history of LIVN is 1.52% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 18 years.
LivaNova PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | LIVN |
CUSIP: | G5509L |
Website: | livanova.com |
Debt
Debt-to-Equity Ratio: | 0.48 |
---|---|
Current Ratio: | 3.37 |
Quick Ratio: | 1.75 |
Price-to-Earnings
Trailing P/E Ratio: | 160.91 |
---|---|
Forward P/E Ratio: | 14.2 |
LIVN Technical Analysis vs Fundamental Analysis
Sell
36
LivaNova PLC (LIVN)
is a Sell
Is LivaNova PLC a Buy or a Sell?
-
LivaNova PLC stock is rated a Sell
The current LivaNova PLC [LIVN] share price is $51.49. The Score for LIVN is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.